-
10 Most Promising Contract Research Organizations - 2019
As per Grand View Research's recent study, the global healthcare CRO market size is expected to reach $54.7 billion by 2025, growing at a CAGR of 6.6 percent each year. Many CROs have either enlarged their geographical business to India or enhanced their existing business in the country due to low cost. In India, the cost for clinical trial is approximately 40-70 percent less than US/EU. Thus, many famous industry leaders are presently leveraging the demographic advantage offered by India and dominating the Indian CRO market. Today, the rising population is in urgent need of better medical care which in-turn demands for drug discovery. Pharmaceutical firms and medical devices organizations are facing immense pressure on high drug costs. As a result, they are searching for ways...
-
10 Most Promising Contract Research Organizations - 2019
Propose your Nomination
Our subscribers play a decisive role in finalization of our annual list of Top Contract Research Organizations - 2019 by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
| Company Logo | Company Name | Company Management | Company Description |
|---|---|---|---|
|
Ardent Clinical Research Services | Chandu Devanpally, Founder & MD | With its exhaustive investigator database and technical expertise in diverse areas of therapeutic research, the company enables faster patient recruitment, cost-effective trials and a world-class clinical support in a set turn-around time |
|
ASSAY Clinical Research | Sudharshan M. Chandran, Managing Director | A technology driven CRO working on changing the dynamics of clinical trials via its in-house developed software, clinical trial management solutions & services |
|
Biosite Research | Dr. Aditi Datta, Managing Director | One of the leading mid-sized Indian clinical CRO guiding clients from clinical development planning to regulatory filing, providing flexible solutions whilst ensuring budget and deadlines are met with reduced client risks and delays |
|
CliniRX | Rita Karia, President & CEO | A full service mid-size CRO that provides comprehensive end-to- end solutions and services for clinical studies, including Phase-II, III and late Phase (Phase IV) across numerous therapeutic areas and specialties |
|
Innovate Research | Dr. Devesh Kumar, Founder & Managing Director | Offering a full range of services, including biostatistics, data management, project management, study monitoring, patient recruitment, site, investigator management & global safety and pharmacovigilance with its vast expertise in different therapeutic areas |
|
Navitas Life Sciences | Govind Srinivasana, VP-Technology | A platform-driven full-service Clinical, Regulatory and Safety solutions & services company having 30 years of rich experience across 400+ phase I-IV clinical trials, 1000 bioequivalence studies, 20+ therapeutic areas, and 40+ successful GCP/non-GCP audits |
|
SIRO Clinpharm | Akshay Daftary & Karan Daftary, Directors - Business Development | An industry pioneer sharing an incontestable record of excellence in the pharmaceutical, FMCG and medical device industry, offering a range of services from clinical operations to data services, data analytics and medical writing in compliance with international standards |
|
Syngene International | Jonathan Hunt, CEO | An internationally reputed contract research and manufacturing organization which supports R&D programs, right from lead generation to clinical supplies |
|
Vanta Bioscience | Dopesh Mulakala, Managing Director | A full service GPL certified preclinical contract research organization catering to pharmaceutical, biotech, medical device, cosmetics and many other industries |